Michael M. Goldberg
2017
In 2017, Michael M. Goldberg earned a total compensation of $846.1K as President and Chief Executive Officer at Navidea Biopharmaceuticals, a 336% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $410,768 |
|---|---|
| Salary | $427,222 |
| Other | $8,067 |
| Total | $846,057 |
Goldberg received $427.2K in salary, accounting for 50% of the total pay in 2017.
Goldberg also received $410.8K in non-equity incentive plan and $8.1K in other compensation.
Rankings
In 2017, Michael M. Goldberg's compensation ranked 9,786th out of 14,666 executives tracked by ExecPay. In other words, Goldberg earned more than 33.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,786 out of 14,666 | 33rd |
Division Manufacturing | 3,782 out of 5,772 | 35th |
Major group Chemicals And Allied Products | 1,314 out of 2,075 | 37th |
Industry group Drugs | 1,061 out of 1,731 | 39th |
Industry In Vitro and In Vivo Diagnostic Substances | 37 out of 72 | 49th |
Source: SEC filing on June 28, 2019.
Goldberg's colleagues
We found two more compensation records of executives who worked with Michael M. Goldberg at Navidea Biopharmaceuticals in 2017.